News Highlights: Top Company News of the Day
Can Gap Escape the Whirlwind? New CEO Confronts Years of Decline
Sonia Syngal must defy the vortex consuming companies that
weren't prepared for the Covid crisis. She is plotting a future of
fewer stores and more fashion risks to revive the company's
Hasbro Posts Rise in 3Q Profit
Hasbro logged a third-quarter profit of $220 million, or $1.61 a
share, but revenue from the company's operations that rely on live
events suffered during coronavirus pandemic.
Dunkin' Brands in Talks to Be Acquired by Arby's Parent
The parent of Dunkin' and Baskin-Robbins said it has held early
talks to go private in an acquisition by Inspire Brands, whose
portfolio includes Arby's, Buffalo Wild Wings and Jimmy John's
Oxford, AstraZeneca Vaccine Shows Promising Immune Response in Older Adults
A Covid-19 vaccine being developed by the University of Oxford
and AstraZeneca showed a promising immune response and low levels
of adverse reactions in the elderly and older adults, according to
an interim analysis.
SAP Profit Warning Sends Shares Plummeting
Shares in Europe's biggest tech company plunged after it
scrapped its profit targets for the year and said measures to
thwart a rebound in coronavirus infections would weigh on business
through the middle of next year.
Ant to Raise More Than $34 Billion in Record IPO
In what is due to be the world's biggest-ever initial public
offering, Ant Group will be one of the most valuable companies in
either technology or finance.
Facebook Moves Into Cloud Gaming
The social-media company's free-to-play model differs from the
paid, subscription cloud-gaming services of rivals such as Google
Auto Makers Shift Hydrogen Focus to Big Rigs
Auto makers have spent decades developing hydrogen fuel cells as
a green alternative for cars with little to show for it. Now, they
are shifting their attention to the trucking industry.
Bayer to Buy Gene-Therapy Firm AskBio for Up to $4 Billion
Bayer intends to acquire U.S.-based Asklepios BioPharmaceutical
to strengthen the German company's drugmaking arm, as Bayer
continues to reel from its acquisition of crops giant Monsanto.
Coca-Cola Backs Away From Bottling in Australia as Deal Bubbles to Sell Stake
Coca-Cola agreed in principle to sell its stake in its
Australian bottler to one of its European affiliates, its latest
move to reduce exposure to costly bottling operations and focus on
the more lucrative concentrate-making business.
(END) Dow Jones Newswires
October 26, 2020 13:15 ET (17:15 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.